PCSK9 and coronary artery disorder: To the best of our knowledge, this was the first study to investigate the effects of PCSK9 inhibitors on CAC progression in a randomized controlled study comparing PCSK9 inhibitors vs. standard statins therapy in patients with coronary artery disease.